This is the authors' abstract. We don't add key points for this paper.
The β-adrenergic receptor kinase (βARK) modulates β-adrenergic and other G protein-coupled receptors by rapidly phosphorylating agonist-occupied receptors at the plasma membrane. We have recently shown that βARK also associates with intracellular microsomal membranes both “in vitro” and “in situ” (García-Higuera, I., Penela, P., Murga, C., Egea, G., Bonay, P., Benovic, J. L., and 5or, F., Jr. (1994) J. Biol. Chem. 269, 1348-1355), thus suggesting a complex modulation of the subcellular distribution of βARK. In this report, we used recombinant [35S]methionine-labeled βARK to show that this kinase interacts rapidly with a high affinity binding site (Kd of 20 ± 1 nM) present in salt-stripped rat liver microsomal membranes. Although βARK binding is not modulated by membrane preincubation with G protein activators, the activity of bound βARK toward rhodopsin or a synthetic peptide substrate was markedly enhanced upon stimulation of the endogenous heterotrimeric G proteins present in the microsomal membranes by AlF4− or mastoparan/guanosine 5′-(3-O-thio)triphosphate, thus strongly suggesting a functional link between these proteins and membrane-associated βARK. Interestingly, βARK association with microsomal membranes is not significantly affected by a fusion protein derived from the carboxyl terminus of βARK1 (the proposed location of the βγ subunit binding site), whereas it is markedly inhibited by fusion proteins corresponding to the amino-terminal region of the kinase. The main determinants of binding appear to be localized to an ∼60-amino acid residue stretch (residues 88 to 145). Our results further indicate a functional relationship between βARK and heterotrimeric G proteins in different intracellular organelles, and suggest that additional proteins may be involved in modulating the cellular localization of the kinase through a new targeting domain of βARK. The β-adrenergic receptor kinase (βARK) modulates β-adrenergic and other G protein-coupled receptors by rapidly phosphorylating agonist-occupied receptors at the plasma membrane. We have recently shown that βARK also associates with intracellular microsomal membranes both “in vitro” and “in situ” (García-Higuera, I., Penela, P., Murga, C., Egea, G., Bonay, P., Benovic, J. L., and 5or, F., Jr. (1994) J. Biol. Chem. 269, 1348-1355), thus suggesting a complex modulation of the subcellular distribution of βARK. In this report, we used recombinant [35S]methionine-labeled βARK to show that this kinase interacts rapidly with a high affinity binding site (Kd of 20 ± 1 nM) present in salt-stripped rat liver microsomal membranes. Although βARK binding is not modulated by membrane preincubation with G protein activators, the activity of bound βARK toward rhodopsin or a synthetic peptide substrate was markedly enhanced upon stimulation of the endogenous heterotrimeric G proteins present in the microsomal membranes by AlF4− or mastoparan/guanosine 5′-(3-O-thio)triphosphate, thus strongly suggesting a functional link between these proteins and membrane-associated βARK. Interestingly, βARK association with microsomal membranes is not significantly affected by a fusion protein derived from the carboxyl terminus of βARK1 (the proposed location of the βγ subunit binding site), whereas it is markedly inhibited by fusion proteins corresponding to the amino-terminal region of the kinase. The main determinants of binding appear to be localized to an ∼60-amino acid residue stretch (residues 88 to 145). Our results further indicate a functional relationship between βARK and heterotrimeric G proteins in different intracellular organelles, and suggest that additional proteins may be involved in modulating the cellular localization of the kinase through a new targeting domain of βARK.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Murga et al. (1996) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: